ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Gemphire Therapeutics Inc

Gemphire Therapeutics Inc (GEMP)

0.30
0.00
(0.00%)
마감 30 1월 6:00AM
0.00
0.00
(0.00%)
시간외 거래: -

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
0.30
매수가
0.30
매도가
0.3169
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
0.30
개장가
-
최근 거래 시간
마지막 거래 시간
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

GEMP 최신 뉴스

Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals

ANN ARBOR, Mich., Dec. 30, 2019 (GLOBE NEWSWIRE) -- The pending merger between Gemphire Therapeutics Inc. (NASDAQ:GEMP) and NeuroBo Pharmaceuticals, Inc. is currently expected to close after...

Gemphire Therapeutics Announces Stockholder Approval of Proposals Required for Merger with NeuroBo Pharmaceuticals

ANN ARBOR, Mich., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP) announced today that, based upon the final vote count certified by the independent inspector of...

Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company

Transaction to Create Nasdaq-listed Biotechnology Company Focused on Advancing NeuroBo’s Clinical-Stage Pipeline NeuroBo Poised to Advance Lead Drug Candidate into Phase 3 Trials for Neuropathic...

Gemphire Announces Top-Line Data from Familial Partial Lipodystrophy (FPLD) Phase 2a Proof-of-Concept NAFLD/NASH Clinical Tri...

LIVONIA, Mich., June 26, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP) today announced top-line results based upon the Company’s preliminary review of the limited top-line...

Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2018 Financial Results

LIVONIA, Mich., March 15, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...

Gemphire Therapeutics Announces Review of Strategic Alternatives and Provides Corporate Update

LIVONIA, Mich., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...

Gemphire Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

LIVONIA, Mich., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...

Gemphire Therapeutics Announces Workforce Reduction

LIVONIA, Mich., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...

Gemphire Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update

LIVONIA, Mich., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...

Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD

LIVONIA, Mich., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

GEMP - Frequently Asked Questions (FAQ)

What is the current Gemphire Therapeutics share price?
The current share price of Gemphire Therapeutics is US$ 0.30
What is the 1 year trading range for Gemphire Therapeutics share price?
Gemphire Therapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
DGNXDiginex Ltd
US$ 49.18
(228.09%)
3.34M
SLXNSilexion Therapeutics Corporation
US$ 3.1301
(131.86%)
330.45M
KRKR36Kr Holdings Inc
US$ 9.10
(114.12%)
23.61M
SPGCSacks Parente Golf Inc
US$ 0.6001
(57.92%)
52.17M
XFORX4 Pharmaceuticals Inc
US$ 0.7542
(56.54%)
42.5M
ZKINZK International Group Co Ltd
US$ 0.4813
(-41.21%)
3.1M
MGOLMGO Global Inc
US$ 0.1019
(-38.73%)
70.52M
BACKIMAC Holdings Inc
US$ 0.7869
(-35.50%)
2.37M
EYENEyenovia Inc
US$ 0.03695
(-35.18%)
25.31M
HAOHaoxi Health Technology Ltd
US$ 2.52
(-31.89%)
484.94k
NVDANVIDIA Corporation
US$ 123.70
(-4.10%)
466.94M
SLXNSilexion Therapeutics Corporation
US$ 3.1301
(131.86%)
330.45M
OCEAOcean Biomedical Inc
US$ 0.249929
(-24.26%)
186.52M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.428
(-6.98%)
148.12M
RIMEAlgorhythm Holdings Inc
US$ 0.0259
(-16.18%)
138.96M

GEMP Discussion

게시물 보기
Cowman45 Cowman45 5 년 전
Why does this keep dropping with merger news?
👍️0
Cowman45 Cowman45 5 년 전
Ok the 8k on the 9th, item 3.01, mentions a r/s. 8k on the 15th, item 3.01, makes no mention..... which is it??
👍️0
Cowman45 Cowman45 6 년 전
A lot of form 4s yesterday for acquiring shares.....
👍️0
ClayTrader ClayTrader 6 년 전
* * $GEMP Video Chart 07-25-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
stock1ace1 stock1ace1 6 년 전
In 1.09 lets go
👍️0
behindthebid behindthebid 6 년 전
Everything You Need For Your Premarket Including Gemplus/NeuroBo

Gemplus reverse merging today with private biotech NeuroBo. Every day there is a Premarket Breakfast post with what's going on, why, gappers and sentiment. Today's Post is at

https://www.behindthebid.com/posts/premarket-breakfast-for-thursday-july-25th
👍️0
tavito tavito 6 년 전
Yes, they’ve been relentless.
👍️0
willlbone willlbone 6 년 전
So dilution likely.
👍️0
ClayTrader ClayTrader 6 년 전
* * $GEMP Video Chart 09-13-18 * *

Link to Video - click here to watch the technical chart video

👍️0
PAC PAC 6 년 전
Going to be hard. If it does, either GREAT news or work thru that area
👍️0
otchype otchype 6 년 전
going to pass 3.27?
👍️0
otchype otchype 6 년 전
going to pass 3.27?
👍️0
jdlamont jdlamont 6 년 전
There not saying it anymore since phase 2 was terminated because their drug made people sicker!!!
Nice call RJ.
Whatever RJ says to buy should be shorted.
👍️0
otchype otchype 6 년 전
They didn't say when, this year is far from over1
👍️0
gamesetmatch101 gamesetmatch101 6 년 전
Raymond James idiots had price target raised to 40 before the crash.
👍️0
PAC PAC 6 년 전
YES, and some
👍️0
Franky-vincent Franky-vincent 6 년 전
will we fill the gap?
👍️0
VERITAS77 VERITAS77 6 년 전
There it is.
👍️0
ClayTrader ClayTrader 6 년 전
* * $GEMP Video Chart 09-06-18 * *

Link to Video - click here to watch the technical chart video

👍️0
incredible199 incredible199 6 년 전
Finally we see that breakout. Nice day
👍️0
PAC PAC 6 년 전
YES SIR GEMP 2.30 +45%
👍️0
simmons420 simmons420 6 년 전
Booom town break into the gap, Long swing
👍️0
aristotelisonassis aristotelisonassis 6 년 전
long
👍️0
PAC PAC 6 년 전
GEMP 1.47 stepping up
👍️0
Warchest Warchest 6 년 전
SQUEEZE ??? !!!
👍️0
PAC PAC 6 년 전
GEMP 1.40 triple dips down here. Any ramp up, it's flying
👍️0
hwpbnj hwpbnj 6 년 전
Cool
👍️0
VERITAS77 VERITAS77 6 년 전
I made money.
Soo who's lol.
Lol.

Johnny come lately.
And I'm still holding 2019 contract.
Plus a beat on Earnings
👍️0
hwpbnj hwpbnj 6 년 전
Lol
👍️0
PAC PAC 6 년 전
GEMP 1.60 watching for setup. Gap fill 3
👍️0
VERITAS77 VERITAS77 6 년 전
$2+ building.. 7 million Friday volume Sell off only 200k shares
👍️0
VERITAS77 VERITAS77 6 년 전
3.38 premarket mm ask short squeeze
Possible $5 run plus earnings and gap fills 6 plus Alert.
Last alert @.86 cents
Pfizer pipeline future deals.
👍️0
ClayTrader ClayTrader 6 년 전
* * $GEMP Video Chart 08-10-18 * *

Link to Video - click here to watch the technical chart video

👍️0
VERITAS77 VERITAS77 6 년 전
$2.44 CASH micro float Alert
👍️0
hwpbnj hwpbnj 6 년 전
Ewwww
👍️0
hwpbnj hwpbnj 6 년 전
Weeeeeeeeee news pending
👍️0
hwpbnj hwpbnj 7 년 전
Should make for an okay swing trade
👍️0
now invest now invest 7 년 전
Well. With RJ raising the target last week to $26 after their test results... I am watching to see if this sleeper will be as good as another one they have..... so just added 500 @ 7.80. IF the market allows it to go lower... will be looking to add more!!!
👍️0
hwpbnj hwpbnj 7 년 전
Pumpdee starts back up tomorrow into Monday
👍️0
hwpbnj hwpbnj 7 년 전
?
👍️0
stocktrademan stocktrademan 7 년 전
GEMP buy 10.19

news catalyst http://ih.advfn.com/p.php?pid=nmona&article=77766693
resistance breakout























normal chart




log chart



👍️0
Biggeoff Biggeoff 7 년 전
GEMP having buyout rumors. Stock should explode from these levels. Up to $16
👍️0
protagonist12 protagonist12 8 년 전
GEMP is now Gemphire Therapeutics Inc which IPOd in August '16, Gemplus International SA was merged with Axalto on June 2, 2006.
👍️0
hp435 hp435 8 년 전
Great company with a great product waiting for fda approval of 2nd stage trial
👍️0
Hacktheripper Hacktheripper 21 년 전
Grub

👍️0
2bStealthy 2bStealthy 21 년 전
MSFT to use GEMP SC solution!

http://biz.yahoo.com/prnews/040224/ukm010_1.html

Gemplus Powers Microsoft's Technology Centers with Smart Cards for Network Security
Tuesday February 24, 2:00 am ET

LUXEMBOURG and HORSHAM, Pennsylvania, February 24 /PRNewswire-FirstCall/ --

Microsoft Technology Centers Around the World Demonstrate Gemplus Smart Cards for Network Security in Windows-based Environments

Gemplus International S.A. (Euronext: LU0121706294 - GEM, NASDAQ:GEMP), the world's leading provider of smart card solutions, today announces the delivery of smart cards, readers, and software to Microsoft for use in the Microsoft Technology Centers around the world. Microsoft will use Gemplus technology to demonstrate to clients the integration and implementation of smart cards in a Windows-based environment for network security.

Microsoft plans to install Gemplus readers and software in its technology centers in the United States (five locations: Redmond, WA; Boston, MA; Chicago, IL; Austin, TX; Silicon Valley), Germany, England, Taiwan, Japan, and China during the first half of 2004. Corporate enterprise visitors will be able to see Gemplus smart cards used during demonstrations to securely log-on to PCs, digitally sign e-mails, and perform remote log-ons using a virtual private network.

"We see a growing need among our large enterprise customers to learn more about smart cards and security technologies that support single sign-on and two-factor authentication within Windows-based environments. We are pleased to demonstrate solutions using these technologies and value Gemplus's support in providing the smart card hardware and software components to make this possible," said Brian Groth, Group Program Manager, Microsoft.

Smart cards are experiencing increased adoption with many companies around the world that are looking to enhance the security and flexibility of their employee badge programs. Gemplus's U.S. Corporate Security Systems Study, which was carried out by Frost & Sullivan, showed that 30% of Fortune 500 companies surveyed are currently using or testing smart cards within their security systems and more than one-third of the companies surveyed plan to use smart cards within their corporate security systems within the next three years.

The Microsoft Technology Centers will use smart cards, PC-link readers, and software from Gemplus's SafesITe solution. SafesITe provides customers and system integrators with all the products (cards, readers & software) and services necessary to seamlessly deploy multi-purpose employee cards as part of an organization's existing infrastructure. SafesITe supports Microsoft Windows.

"Gemplus is excited to support Microsoft in its effort to educate enterprises on the benefits of smart cards within an identity infrastructure ," said Dave Ludin, Gemplus's Vice President of Financial and Security Solutions in North America. "Smart cards offer a versatile platform to combine building access and network security on one card, offering strong protection of IT assets while providing convenience to employees who can access many services with one card."

To learn more about the technology used in Microsoft's technology centers and Gemplus's SafesITe solution, please visit the Gemplus booth #521 at the RSA Security Conference 2004 in San Francisco, CA from February 24-26.
👍️0

최근 히스토리

Delayed Upgrade Clock